About Us

MISSION STATEMENT: The HIV+Hepatitis Policy Institute promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.

Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.

Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.

Our Team

CARL SCHMID

Executive Director, HIV+Hepatitis Policy Institute, Washington, D.C.

cschmid@hivhep.org

Carl Schmid has been a national policy and advocacy leader in the HIV community for over 20 years.  He spent 16 years with The AIDS Institute, serving as its Deputy Executive Director. In December 2019, he formed the HIV+Hepatitis Policy Institute, which promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.

Mr. Schmid leads advocacy efforts to ensure domestic HIV and hepatitis programs are based on sound public policy and fully funded. He has expertise in healthcare financing systems, including Medicaid and Medicare, and leads efforts to ensure that the Affordable Care Act meets the needs of beneficiaries, including prescription medications.

From December 2018 to August 2021 he served as Co-Chair of the Presidential Advisory Council on HIV/AIDS (PACHA). He currently serves as a member of PACHA and as a consumer representative to the National Association of Insurance Commissioners. 

He is a cancer survivor and living with chronic hepatitis B.

Mr. Schmid earned a B.A. in Public Affairs and an M.B.A. in International Affairs from the George Washington University in Washington, D.C.

Scott Palmer

Executive Assistant

spalmer@hivhep.org

Ann Lefert

The Lefert Group

Policy Consultant

ann@thelefertgroup.com

Jennifer Burke

Communications Consultant

jburke@hivhep.org

Board Members

CARL SCHMID

President

Executive Director

HIV+Hep Policy Institute

Washington, DC

REKHA RAMESH

Treasurer 

Vice President, Head of Global Policy

Gilead Sciences, Inc.

Foster City, CA

JUSTIN C. SMITH MS, MPH

Secretary

Director, Campaign to End AIDS

Positive Impact Health Centers

Atlanta, GA

JAMES CAREY

Head of U.S. Government Affairs and Policy

Organon and Co.

Washington, DC

MARC MEACHEM

Director of External Affairs

ViiV Healthcare

Washington, DC

RAFAELÉ NARVÁEZ

Co-Founder

Latinos Salud

Oakland Park, FL

ANDREW SPERLING

Mental Health Advocate 

Arlington, VA

PAM TRAXEL

Senior Vice President

American Cancer Society

Cancer Action Network

Washington, DC

STEVEN R. YOUNG

Former Director

HIV/AIDS Bureau, HRSA, HHS

Yardley, PA

Funders for HIV+Hepatitis Policy Institute

HIV+Hep appreciates the support of numerous funders, and recognizes those below that are our corporate members and sponsors:

Get Involved

Facebook posts by @HIV+Hep

Tweets by @HIV+Hep

Concerning the proposed @SenateApprops FY22 spending to #endHIV, @HIVHep’s Carl Schmid writes: “[It] is reassuring that Congress, in a bicameral & bipartisan fashion, is in agreement that we can & must end HIV, & are prioritizing $ ↑ for progs" to do so: https://t.co/oU4BrN0kvl.
Advisors Ask White House to Expand Private Sector Role in HIV Fight https://t.co/BG7wohIkPm
@HIVHep AARDA, & dozens of other patient groups come together to urge @HHSGov to issue regulations that protect #patients and ensure #insurers count copay assistance towards patient out-of-pocket costs and deductibles. Press release: https://t.co/O86v70u62a https://t.co/HqISdJyqao HIVHep photo
@HIVHep’s Carl Schmid writes that the @SenateApprops FY22 total funding proposes $700m to #endHIV & calls this investment “pivotal to address the ongoing disparities in the HIV epidemic, 40 years after researchers 1st discovered this infectious disease”: https://t.co/oU4BrN0kvl. https://t.co/BvF8LxbeYs HIVHep photo

Pin It on Pinterest

Share This